Demographics of a large cohort of urban chronic hepatitis C patients
- PMID: 19669268
- PMCID: PMC2716882
- DOI: 10.1007/s12072-008-9086-x
Demographics of a large cohort of urban chronic hepatitis C patients
Abstract
Purpose: Recent studies suggest that African Americans (AA) with chronic hepatitis C (CHC) differ from non-Hispanic whites (NHW) with respect to the natural history and mortality resulting from the complications of chronic liver disease. The aim of this study was to examine the demographics of a large cohort of CHC patients and identify potential differences between AA and NHW.
Methods: This is a retrospective analysis, consisting of 2,739 hepatitis C antibody-positive patients seen at Wayne State University between 1995 and 2005. Patient demographics, risk factors, comorbidities, alanine aminotransferase (ALT), aspartate aminotransferase (AST), serum hepatitis C (HCV) RNA levels, genotype, and liver biopsy results were recorded.
Results: AA constituted 75.4%, NHW 22.5%, and Asians or Hispanics 2.1% of the patients. Males predominated (58%), and the mean age of AA and NHW was 50.0 and 45.3 years, respectively (P </= 0.001). The most common risk factor was injection drug use in 55.3% (AA 57.1% vs. NHW 49.7%; P </= 0.002). HCV RNA by PCR obtained in 2,407 patients was positive in 94.8%, with a high viral load in 61%. Genotype 1 was significantly more frequent in AA (92.6%) than in NHW (70.6%, P </= 0.001). AA had lower median ALT levels (P </= 0.001). In those patients who were biopsied, there was no significant difference in fibrosis between the two groups. Aspartate to platelet index calculated in those patients who were not biopsied showed significantly lower fibrosis scores in AA.
Conclusions: In this large cohort of CHC patients from a single institution, AA were older at presentation, had a higher prevalence of genotype 1, but significantly lower ALT levels than NHW.
References
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'PubMed', 'value': '0', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/0/'}]}
- Edlin BR. Five million Americans infected with the Hepatitis C virus: a corrected estimate. Hepatology 2005;42(4, Suppl 1):44 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1056/NEJM199908193410802', 'is_inner': False, 'url': 'https://doi.org/10.1056/nejm199908193410802'}, {'type': 'PubMed', 'value': '10451460', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/10451460/'}]}
- Alter MJ, Jruzon-Moran MS, Nanina O, Mcquillan GM, Gao F, Margolis H, et al. The prevalence of hepatitis C infection in the United States, 1988 through 1994. New Engl J Med 1999;341:556–562 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/S0140-6736(03)15109-4', 'is_inner': False, 'url': 'https://doi.org/10.1016/s0140-6736(03)15109-4'}, {'type': 'PubMed', 'value': '14697814', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/14697814/'}]}
- Poynard T, Yuen M, Ratziu V, Lai CL. Viral hepatitis C. Lancet 2003;362:2095–2100 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1111/j.1572-0241.2002.05555.x', 'is_inner': False, 'url': 'https://doi.org/10.1111/j.1572-0241.2002.05555.x'}, {'type': 'PubMed', 'value': '11922566', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/11922566/'}]}
- Wiley TE, Brown J, Chan J. Hepatitis C infection in African-Americans: its natural history and histological progression. Am J Gastroenterol 2002;97:700–706 - PubMed
-
- {'text': '', 'ref_index': 1, 'ids': [{'type': 'DOI', 'value': '10.1016/j.amjmed.2004.02.043', 'is_inner': False, 'url': 'https://doi.org/10.1016/j.amjmed.2004.02.043'}, {'type': 'PubMed', 'value': '15276594', 'is_inner': True, 'url': 'https://pubmed.ncbi.nlm.nih.gov/15276594/'}]}
- Hepburn MJ, Hepburn LM, Cantu NS, Lapeer MG, Lawitz EJ. Differences in treatment outcome for hepatitis C among ethnic groups. Am J Med 2004;117:163–168 - PubMed